id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-1657-0001,FDA,FDA-2013-E-1657,"Aegerion Pharmacueticals, Inc. (Goodwin Procter LLP) - Paatent Term Application",Other,Application,2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T12:47:13Z,,0,0,09000064814ca53a
FDA-2013-E-1657-0002,FDA,FDA-2013-E-1657,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T12:47:25Z,,0,0,09000064814ca53b